Cargando…

Multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain

Vortioxetine is a multimodal antidepressant that potently antagonizes 5-HT3 serotonin receptors, inhibits the high-affinity serotonin transporter, activates 5-HT1A and 5-HT1B receptors, and antagonizes 5-HT1D and 5-HT7 receptors. 5-HT3 receptors largely mediate the hyperalgesic activity of serotonin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuena, Anna Rita, Maftei, Daniela, Alemà, Giovanni Sebastiano, Dal Moro, Francesca, Lattanzi, Roberta, Casolini, Paola, Nicoletti, Ferdinando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207957/ https://www.ncbi.nlm.nih.gov/pubmed/30289053 http://dx.doi.org/10.1177/1744806918808987

Ejemplares similares

Chemokines in Alzheimer’s Disease: New Insights Into Prokineticins, Chemokine-Like Proteins
por: Zuena, Anna Rita, et al.
Publicado: (2019)

In Vivo Non-radioactive Assessment of mGlu5 Receptor-Activated Polyphosphoinositide Hydrolysis in Response to Systemic Administration of a Positive Allosteric Modulator
por: Zuena, Anna R., et al.
Publicado: (2018)

Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in Mice
por: Teleuca, Ana Elena, et al.
Publicado: (2022)

Prenatal Restraint Stress Generates Two Distinct Behavioral and Neurochemical Profiles in Male and Female Rats
por: Zuena, Anna Rita, et al.
Publicado: (2008)

Faecal corticosterone metabolite assessment in socially housed male and female Wistar rats
por: Cinque, Carlo, et al.
Publicado: (2018)

Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
por: Chen, Grace, et al.
Publicado: (2013)

Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant
por: Wang, Yuan, et al.
Publicado: (2021)

Transplacental Exposure to AZT Induces Adverse Neurochemical and Behavioral Effects in a Mouse Model: Protection by L-Acetylcarnitine
por: Zuena, Anna Rita, et al.
Publicado: (2013)

Correction: Transplacental Exposure to AZT Induces Adverse Neurochemical and Behavioral Effects in a Mouse Model: Protection by L-Acetylcarnitine
por: Zuena, Anna Rita, et al.
Publicado: (2013)

In vivo electrophysiological study of the targeting of 5‐HT(3) receptor‐expressing cortical interneurons by the multimodal antidepressant, vortioxetine
por: Schweimer, Judith V., et al.
Publicado: (2022)

Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats
por: Leiser, S C, et al.
Publicado: (2014)

Clinical Switching Strategies of Various Antidepressants to Vortioxetine in the PREDDICT Trial
por: Mills, Natalie T, et al.
Publicado: (2020)

Maternal exposure to low levels of corticosterone during lactation protects adult rat progeny against TNBS-induced colitis: A study on GR-mediated anti-inflammatory effect and prokineticin system
por: Zinni, Manuela, et al.
Publicado: (2017)

Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men
por: Wilson, Sue, et al.
Publicado: (2015)

Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update
por: Adamo, Daniela, et al.
Publicado: (2021)

PS110. Reversal of stress-induced anhedonia by the multimodel antidepressant, vortioxetine
por: Christensen, AK, et al.
Publicado: (2016)

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder
por: Katona, Cornelius L, et al.
Publicado: (2014)

Catecholaminergic and Cholinergic Systems Mediate Beneficial Effect of Vortioxetine on Diabetes-Induced Neuropathic Pain
por: Turan Yücel, Nazlı, et al.
Publicado: (2023)

Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism
por: Leiser, Steven C, et al.
Publicado: (2015)

Prokineticin 2 Upregulation in the Peripheral Nervous System Has a Major Role in Triggering and Maintaining Neuropathic Pain in the Chronic Constriction Injury Model
por: Lattanzi, Roberta, et al.
Publicado: (2015)

Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder
por: Kotzalidis, Georgios D., et al.
Publicado: (2021)

Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant
por: Hsiao, Hung-Tsung, et al.
Publicado: (2022)

Depression and Cerebrovascular Disease: Could Vortioxetine Represent a Valid Treatment Option?
por: Carta, Mauro Giovanni, et al.
Publicado: (2015)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
por: McIntyre, Roger S
Publicado: (2017)

Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
por: Notartomaso, Serena, et al.
Publicado: (2017)

Multimodal analgesia or balanced analgesia: the better choice?
por: Shim, Jae Hang
Publicado: (2020)

Analgesic Mechanisms of Antidepressants for Neuropathic Pain
por: Obata, Hideaki
Publicado: (2017)

Activation of mTORC1 Signaling Cascade in Hippocampus and Medial Prefrontal Cortex Is Required for Antidepressant Actions of Vortioxetine in Mice
por: Li, Wei-Yu, et al.
Publicado: (2023)

The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
por: Lattanzi, Roberta, et al.
Publicado: (2021)

Vortioxetine: Clinical Pharmacokinetics and Drug Interactions
por: Chen, Grace, et al.
Publicado: (2017)

Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients
por: Findling, Robert L., et al.
Publicado: (2017)

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population
por: Miao, Jia, et al.
Publicado: (2019)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Clinical effectiveness of vortioxetine in postcovid syndrome
por: Vikarenko, M., et al.
Publicado: (2022)

Identification and Characterization of a New Splicing Variant of Prokineticin 2
por: Lattanzi, Roberta, et al.
Publicado: (2022)

Identification of Regions Involved in the Physical Interaction between Melanocortin Receptor Accessory Protein 2 and Prokineticin Receptor 2
por: Fullone, Maria Rosaria, et al.
Publicado: (2022)

Arginine 125 Is an Essential Residue for the Function of MRAP2
por: Fullone, Maria Rosaria, et al.
Publicado: (2022)

Potential Clinical Role of Prokineticin 2 (PK2) in Neurodegenerative Diseases
por: Maftei, Daniela, et al.
Publicado: (2022)

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease
por: Caruso, Giuseppe, et al.
Publicado: (2021)

The neuropathic pain: An overview of the current treatment and future therapeutic approaches
por: Cavalli, Eugenio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ss09norkveaeii5vfdklm6o350